These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645 [TBL] [Abstract][Full Text] [Related]
13. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis. Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887 [TBL] [Abstract][Full Text] [Related]
14. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases. Karagkounis G; Torbenson MS; Daniel HD; Azad NS; Diaz LA; Donehower RC; Hirose K; Ahuja N; Pawlik TM; Choti MA Cancer; 2013 Dec; 119(23):4137-44. PubMed ID: 24104864 [TBL] [Abstract][Full Text] [Related]
15. Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases. Kobayashi S; Nakamura Y; Taniguchi H; Odegaard JI; Nomura S; Kojima M; Sugimoto M; Konishi M; Gotohda N; Takahashi S; Yoshino T Ann Surg Oncol; 2021 Aug; 28(8):4744-4755. PubMed ID: 33393041 [TBL] [Abstract][Full Text] [Related]
16. Distinct Genomic Profiles are Associated With Conversion to Resection and Survival in Patients With Initially Unresectable Colorectal Liver Metastases Treated With Systemic and Hepatic Artery Chemotherapy. Datta J; Narayan RR; Goldman DA; Chatila WK; Gonen M; Strong J; Balachandran VP; Drebin JA; Kingham TP; Jarnagin WR; Schultz N; Kemeny NE; D'Angelica MI Ann Surg; 2022 Nov; 276(5):e474-e482. PubMed ID: 33214457 [TBL] [Abstract][Full Text] [Related]
17. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis. Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246 [TBL] [Abstract][Full Text] [Related]
18. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Role of BRAF Mutations in Colorectal Cancer Liver Metastases. Pikoulis E; Margonis GA; Andreatos N; Sasaki K; Angelou A; Polychronidis G; Pikouli A; Riza E; Pawlik TM; Antoniou E Anticancer Res; 2016 Sep; 36(9):4805-11. PubMed ID: 27630332 [TBL] [Abstract][Full Text] [Related]
20. RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases. Denbo JW; Yamashita S; Passot G; Egger M; Chun YS; Kopetz SE; Maru D; Brudvik KW; Wei SH; Conrad C; Vauthey JN; Aloia TA J Gastrointest Surg; 2017 Jan; 21(1):68-77. PubMed ID: 27334313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]